Compressed Influenza Vaccination in U.S. Older Adults: A Decision Analysis
- PMID: 30772149
- PMCID: PMC6469716
- DOI: 10.1016/j.amepre.2018.11.015
Compressed Influenza Vaccination in U.S. Older Adults: A Decision Analysis
Abstract
Introduction: Tradeoffs exist between efforts to increase influenza vaccine uptake, including early season vaccination, and potential decreased vaccine effectiveness if protection wanes during influenza season. U.S. older adults increasingly receive vaccination before October. Influenza illness peaks vary from December to April.
Methods: A Markov model compared influenza likelihood in older adults with (1) status quo vaccination (August-May) to maximize vaccine uptake or (2) vaccination compressed to October-May (to decrease waning vaccine effectiveness impact). The Centers for Disease Control and Prevention data were used for influenza incidence and vaccination parameters. Prior analyses showed that absolute vaccine effectiveness decreased by 6%-11% per month, favoring later season vaccination. However, compressed vaccination could decrease overall vaccine uptake. Influenza incidence was based on average monthly incidence with earlier and later peaks also examined. Influenza strain distributions from two seasons were modeled in separate scenarios. Sensitivity analyses were performed to test result robustness. Data were collected and analyzed in 2018.
Results: Compressed vaccination would avert ≥11,400 influenza cases in older adults during a typical season if it does not decrease vaccine uptake. However, if compressed vaccination decreases vaccine uptake or there is an early season influenza peak, more influenza can result. In probabilistic sensitivity analyses, compressed vaccination was never favored if it decreased absolute vaccine uptake by >5.5% in any scenario; when influenza peaked early, status quo vaccination was favored.
Conclusions: Compressed vaccination could decrease waning vaccine effectiveness and decrease influenza cases in older adults. However, this positive effect is negated when early season influenza peaks occur and diminished by decreased vaccine uptake that could occur with shortening the vaccination season.
Copyright © 2018 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Within-season influenza vaccine waning suggests potential net benefits to delayed vaccination in older adults in the United States.Vaccine. 2018 Sep 18;36(39):5910-5915. doi: 10.1016/j.vaccine.2018.08.007. Epub 2018 Aug 23. Vaccine. 2018. PMID: 30146403
-
Modelling of optimal timing for influenza vaccination as a function of intraseasonal waning of immunity and vaccine coverage.Vaccine. 2019 Oct 16;37(44):6768-6775. doi: 10.1016/j.vaccine.2019.08.069. Epub 2019 Sep 11. Vaccine. 2019. PMID: 31521411
-
Waning of Influenza Vaccine Protection: Exploring the Trade-offs of Changes in Vaccination Timing Among Older Adults.Clin Infect Dis. 2020 Apr 10;70(8):1550-1559. doi: 10.1093/cid/ciz452. Clin Infect Dis. 2020. PMID: 31257422
-
Impact of influenza vaccination on healthcare utilization - A systematic review.Vaccine. 2019 May 27;37(24):3179-3189. doi: 10.1016/j.vaccine.2019.04.051. Epub 2019 Apr 30. Vaccine. 2019. PMID: 31047677
-
Repeated annual influenza vaccination and vaccine effectiveness: review of evidence.Expert Rev Vaccines. 2017 Jul;16(7):1-14. doi: 10.1080/14760584.2017.1334554. Epub 2017 Jun 9. Expert Rev Vaccines. 2017. PMID: 28562111 Review.
Cited by
-
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024-25 Influenza Season.MMWR Recomm Rep. 2024 Aug 29;73(5):1-25. doi: 10.15585/mmwr.rr7305a1. MMWR Recomm Rep. 2024. PMID: 39197095 Free PMC article.
-
Trends and Dynamics of Respiratory Viruses in Hospitalized Children of Fuzhou: Insights Into the Impact of COVID-19 Pandemic Control Measures.Int J Gen Med. 2025 Feb 12;18:759-770. doi: 10.2147/IJGM.S511995. eCollection 2025. Int J Gen Med. 2025. PMID: 39963516 Free PMC article.
-
Can a Two-Dose Influenza Vaccine Regimen Better Protect Older Adults? An Agent-Based Modeling Study.Vaccines (Basel). 2022 Oct 26;10(11):1799. doi: 10.3390/vaccines10111799. Vaccines (Basel). 2022. PMID: 36366307 Free PMC article.
References
-
- Smith NM, Bresee JS, Shay DK, Uyeki TM, Cox NJ, Strikas RA. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55(RR10):1–42. - PubMed
-
- Fiore AE, Shay DK, Haber P, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep. 2007;56(RR06):1–54. - PubMed
-
- Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep. 2010;59(RR-8):1–62. - PubMed
-
- CDC. 2016–17. Influenza Season Vaccination Coverage Report. www.cdc.gov/flu/fluvaxview/reportshtml/reporti1617/reporti/index.html. Accessed November 21, 2018.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous